Health And Family Welfare Department Karnataka Salbutamol Solution and related medicines Tender Mandya 2026

Tender Overview

The procuring organization is the Health And Family Welfare Department Karnataka for a procurement bundle spanning multiple therapeutic categories, including Salbutamol Solution, B Complex Tablets, Povidine Ointment 15GM, Povidine Solution 500ML, ORS Powder 21 GM, Paracetamol formulations, Amoxicillin 500mg tablets, Rabipur vaccine components, Iron sucrose injections, and related items. Estimated value is ₹50,000 with a 24-item BoQ footprint indicating broad pharmaceutical supply requirements for Mandya, Karnataka (PIN 571401). The tender emphasizes supply of listed medicines and consumables under a single contract, with a diverse product mix that covers antibiotics, analgesics, anti-ulcerants, wound care, and essential vaccines. A key differentiator is the heterogenous item set requiring supplier capability across pharmaceutical stocking, cold-chain where applicable, and standard packaging. The current data provides unit-level item names but not quantities or delivery specifics. Prospective bidders should align with standard government procurement practices for state health programs and prepare for phased fulfillment under contract terms.

Technical Specifications & Requirements

• Item scope includes: Salbutamol Syp, Tab Salbutamol 4mg, Paracetamol forms, Cloxin (Amoxicillin) 500mg, Rabipur, I.V. iron sucrose, Gels and ointments (Clotrimazole cream 15GM, Povidine products), Microplaster, Micro adhesive tape, Electrodes gels, ORS powder 21 GM, and several other listed medicines/consumables.
• No explicit technical standards or packaging specifications are provided in the data. The BoQ lists 24 items, but exact quantities, dosage strengths for all items, storage/facility requirements, and delivery milestones are not disclosed. The estimated value of ₹50,000 signals small to mid-scale supply intent for district-level health operations. Bidder should anticipate typical pharmaceutical procurement norms and ensure compliance with general safety and storage guidelines, including cold-chain where vaccines or temperature-sensitive products are involved.
• Tender terms mention an option clause permitting up to 25% quantity variation at contracted rates, with delivery periods adjusted accordingly. Suppliers should plan for potential quantity expansion and schedule extensions while maintaining price integrity. The absence of explicit standards suggests bidders should confirm regulatory compliance and testing wherever applicable during bid submission.

Terms, Conditions & Eligibility

• EMD amount not specified in the data; bidders must verify deposit requirements during bid submission.
• Delivery extension option: up to 25% of contracted quantity; extended delivery time calculated as (increased quantity / original quantity) × original delivery period, with a minimum of 30 days.
• Option clause mechanics: purchaser may apply the extension during currency of contract, potentially affecting delivery commitments.
• Documentation requirements and exact eligibility criteria are not fully enumerated in the provided details; bidders should prepare standard pharmaceutical bid documents and verify with the issuing department for any specific certifications, GMP/GLP considerations, and registration (GST, etc.).
• The tender is Mandya, Karnataka, and responses should be aligned with state health procurement practices and contractor registration norms.